Calcitonin related polypeptide alpha gene polymorphisms according to plasma total homocysteine levels in ischemic stroke patients of Trakya Region
The aim of this study was to determine the genotype distributions of calcitonin related polypeptide alpha (CALCA) gene polymorphisms according to the plasma total homocysteine levels in ischemic stroke patients and patient subtypes selected from Trakya Region. The study included 82 patients and 92 healthy controls. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were used to determine the genotype distributions of CALCA gene polymorphisms. The plasma total homocysteine levels were measured by Immulite 2000XPi homocysteine kits. Significant differences were not found between the group of patients and the control group in terms of CALCA gene polymorphisms genotype distributions (p < 0.05). Significant differences were not found between ischemic stroke patients and healthy controls, in the patient subtypes with ischemic stroke in respect to the CALCA gene polymorphisms genotype distributions according to the plasma total homocysteine levels (p < 0.05). This suggests that the CALCA gene polymorphisms genotype distributions studied according to the plasma total homocysteine levels could not likely be considered a genetic risk factor for ischemic stroke development..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Biotechnology & Biotechnological Equipment - 31(2017), 6, Seite 1184-1191 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nevra Alkanli [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biotechnology |
|---|
| doi: |
10.1080/13102818.2017.1372218 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ064852407 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ064852407 | ||
| 003 | DE-627 | ||
| 005 | 20230309042652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/13102818.2017.1372218 |2 doi | |
| 035 | |a (DE-627)DOAJ064852407 | ||
| 035 | |a (DE-599)DOAJa5b694eb6a7841aebe1db97878204f60 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a TP248.13-248.65 | |
| 100 | 0 | |a Nevra Alkanli |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Calcitonin related polypeptide alpha gene polymorphisms according to plasma total homocysteine levels in ischemic stroke patients of Trakya Region |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The aim of this study was to determine the genotype distributions of calcitonin related polypeptide alpha (CALCA) gene polymorphisms according to the plasma total homocysteine levels in ischemic stroke patients and patient subtypes selected from Trakya Region. The study included 82 patients and 92 healthy controls. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were used to determine the genotype distributions of CALCA gene polymorphisms. The plasma total homocysteine levels were measured by Immulite 2000XPi homocysteine kits. Significant differences were not found between the group of patients and the control group in terms of CALCA gene polymorphisms genotype distributions (p < 0.05). Significant differences were not found between ischemic stroke patients and healthy controls, in the patient subtypes with ischemic stroke in respect to the CALCA gene polymorphisms genotype distributions according to the plasma total homocysteine levels (p < 0.05). This suggests that the CALCA gene polymorphisms genotype distributions studied according to the plasma total homocysteine levels could not likely be considered a genetic risk factor for ischemic stroke development. | ||
| 650 | 4 | |a Ischemic stroke | |
| 650 | 4 | |a CALCA gene polymorphisms | |
| 650 | 4 | |a PCR | |
| 650 | 4 | |a RFLP | |
| 650 | 4 | |a plasma total homocysteine | |
| 650 | 4 | |a patient subtypes | |
| 653 | 0 | |a Biotechnology | |
| 700 | 0 | |a Tammam Sipahi |e verfasserin |4 aut | |
| 700 | 0 | |a Arzu Ay |e verfasserin |4 aut | |
| 700 | 0 | |a Baburhan Guldiken |e verfasserin |4 aut | |
| 700 | 0 | |a Alev Bakir |e verfasserin |4 aut | |
| 700 | 0 | |a Suleyman Serdar Alkanli |e verfasserin |4 aut | |
| 700 | 0 | |a Canan Celebi |e verfasserin |4 aut | |
| 700 | 0 | |a Emre Atilgan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Biotechnology & Biotechnological Equipment |d Taylor & Francis Group, 2016 |g 31(2017), 6, Seite 1184-1191 |w (DE-627)DOAJ000038555 |x 13143530 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2017 |g number:6 |g pages:1184-1191 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/13102818.2017.1372218 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a5b694eb6a7841aebe1db97878204f60 |z kostenfrei |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/13102818.2017.1372218 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1310-2818 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1314-3530 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2017 |e 6 |h 1184-1191 | ||